In Situ Hybridization, Fluorescence
"In Situ Hybridization, Fluorescence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.
| Descriptor ID |
D017404
|
| MeSH Number(s) |
E01.370.225.500.620.670.325.350 E01.370.225.750.600.670.325.350 E05.200.500.620.670.325.350 E05.200.750.600.670.325.350 E05.393.285.350 E05.393.661.475.350
|
| Concept/Terms |
In Situ Hybridization, Fluorescence- In Situ Hybridization, Fluorescence
- Hybridization in Situ, Fluorescent
- FISH Technique
- FISH Techniques
- Technique, FISH
- Techniques, FISH
- Fluorescent in Situ Hybridization
- FISH Technic
- FISH Technics
- Technic, FISH
- Technics, FISH
- Hybridization in Situ, Fluorescence
- In Situ Hybridization, Fluorescent
|
Below are MeSH descriptors whose meaning is more general than "In Situ Hybridization, Fluorescence".
Below are MeSH descriptors whose meaning is more specific than "In Situ Hybridization, Fluorescence".
This graph shows the total number of publications written about "In Situ Hybridization, Fluorescence" by people in this website by year, and whether "In Situ Hybridization, Fluorescence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "In Situ Hybridization, Fluorescence" by people in Profiles.
-
Prognostic significance of copy number gains of MYC detected by fluorescence in situ hybridization in large B-cell lymphoma. Leuk Lymphoma. 2024 Jan; 65(1):26-36.
-
MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma. Hepatology. 2018 08; 68(2):561-573.
-
Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor. Mod Pathol. 2014 Nov; 27(11):1499-1509.
-
Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment. BMC Cancer. 2014 Feb 25; 14:129.
-
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.
-
Aberrant EGFR and chromosome 7 associate with outcome in laryngeal cancer. Laryngoscope. 2005 Jul; 115(7):1212-8.
-
Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):120-4.
-
Status of HER-2 in male and female breast carcinoma. Am J Surg. 2001 Oct; 182(4):389-92.
-
Construction and characterization of a Schistosoma mansoni bacterial artificial chromosome library. Genomics. 2000 Apr 15; 65(2):87-94.
-
Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation. Lancet. 1999 Jan 16; 353(9148):211-2.